Herbert Lepor, MD, and Danil Makarov, MD, MHS discuss treating lower urinary track symptoms (LUTS). They explain why one of the treatments, 5-ARIs, are no longer approved for chemoprevention by the FDA.
Herbert Lepor, MD, and Danil Makarov, MD, MHS discuss treating lower urinary track symptoms (LUTS). They explain why one of the treatments, 5-ARIs, are no longer approved for chemoprevention by the FDA.